- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about ME
Recent news which mentions ME
3 Key Biotech Trends for 2023 And Beyond
May 19, 2023
From Motley Fool
From InvestorPlace
From InvestorPlace
BELLUS Health, Sunrun And Other Big Stocks Moving Higher In Tuesday's Pre-Market Session
April 18, 2023
From Benzinga
Tickers
ME
From Motley Fool
From Motley Fool
From Motley Fool
2 High-Growth Stocks That Could Double Your Money in 5 Years or Less
February 28, 2023
From Motley Fool
This Genetics Stock Could Have Massive Long-Term Potential
February 10, 2023
Tickers
ME
From Motley Fool
Why Tivic Health Systems Are Trading Lower By 55%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
February 09, 2023
From Benzinga
MGM Resorts, Madison Square Garden Entertainment, Cardiovascular Systems And Other Big Stocks Moving Higher On Thursday
February 09, 2023
From Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
February 08, 2023
From Benzinga
7 Former SPACs I Still Own (And What I Think Now)
January 28, 2023
From Motley Fool
3 Penny Stocks That Could Make You Filthy Rich
January 25, 2023
From Motley Fool
My 4 Worst-Performing Stocks and What I Think Now
January 10, 2023
From Motley Fool
Stocks That Hit 52-Week Lows On Friday
January 06, 2023
From Benzinga
Stocks That Hit 52-Week Lows On Thursday
January 05, 2023
From Benzinga
Guardant Health, Novavax And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
December 16, 2022
From Benzinga
25 Meme Stocks to Sell Before They Die
December 15, 2022
From InvestorPlace
The Worst Investment Decision I Made in 2022
December 10, 2022
From Motley Fool
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
December 05, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 29, 2022
November 29, 2022
From Benzinga
The NIH Has Given BioRestorative Therapies A Stamp Of Approval
November 09, 2022
From Benzinga
I Bought 2 SPACs That Haven't Lived Up to Expectations -- Here's Why I'm Still Holding Them
October 28, 2022
From Motley Fool
Bill Gates, Warren Buffett's Initiative For Billionaires To Donate Most Of Their Wealth Sees Sharp Drop In Pledgers In 2022
October 24, 2022
From Benzinga
From Motley Fool
3 Reasons You Should (Still) Be Buying Growth Stocks Right Now
October 05, 2022
Tickers
ME
From Motley Fool
7 Undervalued Reddit Stocks to Buy Before Wall Street Catches On
September 28, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.